Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Regenxbio Inc (NASDAQ: RGNX) closed at $11.69 in the last session, down -6.48% from day before closing price of $12.50. In other words, the price has decreased by -$6.48 from its previous closing price. On the day, 1.42 million shares were traded. RGNX stock price reached its highest trading level at $12.47 during the session, while it also had its lowest trading level at $11.56.
Ratios:
We take a closer look at RGNX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.53 and its Current Ratio is at 3.53. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on June 07, 2024, initiated with a Buy rating and assigned the stock a target price of $38.
On March 11, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $36.
RBC Capital Mkts Upgraded its Sector Perform to Outperform on March 08, 2024, whereas the target price for the stock was revised from $20 to $35.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 03 ’24 when KARABELAS ARGERIS N sold 10,000 shares for $11.56 per share. The transaction valued at 115,588 led to the insider holds 11,286 shares of the business.
KARABELAS ARGERIS N sold 10,100 shares of RGNX for $136,454 on Aug 01 ’24. The Director now owns 11,286 shares after completing the transaction at $13.51 per share. On Aug 01 ’24, another insider, Simpson Curran, who serves as the Chief Executive Officer of the company, sold 100 shares for $15.00 each. As a result, the insider received 1,500 and left with 170,037 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGNX now has a Market Capitalization of 577757184 and an Enterprise Value of 446115072. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.49 while its Price-to-Book (P/B) ratio in mrq is 1.66. Its current Enterprise Value per Revenue stands at 5.01 whereas that against EBITDA is -1.974.
Stock Price History:
Over the past 52 weeks, RGNX has reached a high of $28.80, while it has fallen to a 52-week low of $10.49. The 50-Day Moving Average of the stock is -6.83%, while the 200-Day Moving Average is calculated to be -25.46%.
Shares Statistics:
According to the various share statistics, RGNX traded on average about 553.60K shares per day over the past 3-months and 575550 shares per day over the past 10 days. A total of 49.42M shares are outstanding, with a floating share count of 44.51M. Insiders hold about 9.83% of the company’s shares, while institutions hold 89.89% stake in the company. Shares short for RGNX as of 1724976000 were 6074435 with a Short Ratio of 10.97, compared to 1722384000 on 5193975. Therefore, it implies a Short% of Shares Outstanding of 6074435 and a Short% of Float of 16.08.
